Intest Res Search

CLOSE


Ahead-of Print

  • HOME
  • BROWSE ARTICLES
  • Ahead-of Print

Articles in E-pub version are posted online ahead of regular printed publication.

Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study
Hiromichi Shimizu, Yuko Aonuma, Shuji Hibiya, Ami Kawamoto, Kento Takenaka, Toshimitsu Fujii, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Ryuichi Okamoto
Received December 13, 2023  Accepted March 22, 2024  
DOI: https://doi.org/10.5217/ir.2023.00194    [Epub ahead of print]
PDF    
Close layer
prev next
Intestinal ultrasound for intestinal Behçet disease reflects endoscopic activity and histopathological findings
Katsuki Yaguchi, Reiko Kunisaki, Sho Sato, Kaori Hirai, Misato Izumi, Yoshimi Fukuno, Mami Tanaka, Mai Okazaki, Rongrong Wu, Yurika Nishikawa, Yusuke Matsune, Shunsuke Shibui, Yoshinori Nakamori, Masafumi Nishio, Mao Matsubayashi, Tsuyoshi Ogashiwa, Ayako Fujii, Kenichiro Toritani, Hideaki Kimura, Eita Kumagai, Yukiko Sasahara, Yoshiaki Inayama, Satoshi Fujii, Toshiaki Ebina, Kazushi Numata, Shin Maeda
Received September 25, 2023  Accepted February 26, 2024  
DOI: https://doi.org/10.5217/ir.2023.00129    [Epub ahead of print]
PDF    
Close layer
prev next
Perianal fistulizing lesions of Crohn’s disease are associated with long-term behavior and its transition: a Chinese cohort study
Wei Zhan, Xiaoyin Bai, Hong Yang, Jiaming Qian
Received February 1, 2024  Accepted April 22, 2024  
DOI: https://doi.org/10.5217/ir.2024.00021    [Epub ahead of print]
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Early resolution of bowel urgency by budesonide foam enema results in improved quality of life in patients with ulcerative colitis: a multicenter prospective observational study
Taku Kobayashi, Kei Moriya, Toshimitsu Fujii, Shigeki Bamba, Shinichiro Shinzaki, Akihiro Yamada, Takashi Hisabe, Shintaro Sagami, Shuji Hibiya, Takahiro Amano, Noritaka Takatsu, Katsutoshi Inagaki, Ken-ichi Iwayama, Toshifumi Hibi
Received January 11, 2024  Accepted April 29, 2024  
DOI: https://doi.org/10.5217/ir.2024.00005    [Epub ahead of print]
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Filgotinib induction-study baseline characteristics of patients with ulcerative colitis who achieve sustained corticosteroid-free remission: post hoc analysis of the phase 2b/3 SELECTION study
Taku Kobayashi, Axel Dignass, Xavier Roblin, Yoshie Takatori, Toshihiko Kaise, Alessandra Oortwijn, Corinne Jamoul, Toshifumi Hibi
Received January 17, 2024  Accepted April 15, 2024  
DOI: https://doi.org/10.5217/ir.2024.00007    [Epub ahead of print]
PDF    
Close layer
prev next
Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities
Kanishk Aggarwal, Bhupinder Singh, Abhishek Goel, Durgesh Kumar Agrawal, Sourav Bansal, Sai Gautham Kanagala, Fnu Anamika, Aachal Gupta, Rohit Jain
Received December 31, 2023  Accepted April 15, 2024  
DOI: https://doi.org/10.5217/ir.2024.00001    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis
Ryo Karashima, Shintaro Sagami, Yoko Yamana, Masa Maeda, Aya Hojo, Yusuke Miyatani, Masaru Nakano, Takahisa Matsuda, Toshifumi Hibi, Taku Kobayashi
Received September 27, 2023  Accepted April 9, 2024  
DOI: https://doi.org/10.5217/ir.2023.00135    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study
Kijae Jo, Kwang Woo Kim, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim, Seong-Joon Koh
Received March 20, 2024  Accepted April 15, 2024  
DOI: https://doi.org/10.5217/ir.2024.00044    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
What to do when traditional rescue therapies fail in acute severe ulcerative colitis
Christopher F. D. Li Wai Suen, Matthew C. Choy, Peter De Cruz
Received January 7, 2024  Accepted March 22, 2024  
DOI: https://doi.org/10.5217/ir.2024.00003    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Adequacy of sigmoidoscopy as compared to colonoscopy for assessment of disease activity in patients of ulcerative colitis: a prospective study
Sameet Tariq Patel, Anuraag Jena, Sanjay Chandnani, Shubham Jain, Pankaj Nawghare, Saurabh Bansal, Harsh Gandhi, Rishikesh Malokar, Jay Chudasama, Prasanta Debnath, Seemily Kahmei, Rima Kamat, Sangeeta Kini, Qais Q Contractor, Pravin M Rathi
Received November 15, 2023  Accepted March 11, 2024  
DOI: https://doi.org/10.5217/ir.2023.00174    [Epub ahead of print]
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Halitosis: an underestimated but important extraintestinal manifestation in inflammatory bowel disease
Xiao Xian Qian
Received January 6, 2024  Accepted February 26, 2024  
DOI: https://doi.org/10.5217/ir.2024.00016    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Ulcerative colitis-associated neoplasms often harbor poor prognostic histologic components with low detection by biopsy
Ryoya Sakakibara, Shinya Sugimoto, Kaoru Takabayashi, Hiroki Kiyohara, Yusuke Wakisaka, Yuta Kaieda, Miho Kawaida, Yusuke Yoshimatsu, Tomohisa Sujino, Naoki Hosoe, Motohiko Kato, Masayuki Shimoda, Yohei Mikami, Yasushi Iwao, Takanori Kanai
Received January 5, 2024  Accepted March 5, 2024  
DOI: https://doi.org/10.5217/ir.2024.00006    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling study
Danny Con, Peter De Cruz
Received November 17, 2023  Accepted February 15, 2024  
DOI: https://doi.org/10.5217/ir.2023.00175    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Efficacy of serum leucine-rich alpha-2 glycoprotein in predicting findings of Crohn’s disease small bowel lesion in capsule endoscopy
Teppei Omori, Miki Koroku, Shun Murasugi, Ayumi Ito, Maria Yonezawa, Shinichi Nakamura, Katsutoshi Tokushige
Received October 6, 2023  Accepted February 26, 2024  
DOI: https://doi.org/10.5217/ir.2023.00139    [Epub ahead of print]
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Changes in the clinical course and prognosis of ulcerative colitis in Chinese populations: a retrospective cohort study
Xinyu Liu, Qingfan Yang, Na Diao, Jian Tang, Zicheng Huang, Xiang Gao, Kang Chao
Received August 21, 2023  Accepted February 29, 2024  
DOI: https://doi.org/10.5217/ir.2023.00106    [Epub ahead of print]
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Cardiovascular disease: extraintestinal manifestation of inflammatory bowel disease
Samridhi Lakhanpal, Kanishk Aggarwal, Harmanjit Kaur, Kunal Kanwar, Vasu Gupta, Jill Bhavsar, Rohit Jain
Received August 20, 2023  Accepted November 6, 2023  
DOI: https://doi.org/10.5217/ir.2023.00104    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab
Hisashi Shiga, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Rintaro Moroi, Yoichi Kakuta, Yoshitaka Kinouchi, Atsushi Masamune
Received December 27, 2023  Accepted February 19, 2024  
DOI: https://doi.org/10.5217/ir.2023.00203    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective
Amal Arifi Hidayat, Langgeng Agung Waskito, Titong Sugihartono, Hafeza Aftab, Yudith Annisa Ayu Rezkitha, Ratha-korn Vilaichone, Muhammad Miftahussurur
Received December 20, 2023  Accepted February 15, 2024  
DOI: https://doi.org/10.5217/ir.2023.00199    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea
Jung Hyun Ji, Seung Hwan Shin, Yong Eun Park, Jihye Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Sang-Bum Kang, Sang Hyoung Park, Soo Jung Park, IBD Research Group of the Korean Association for the Study of Intestinal Diseases (KASID)
Received July 3, 2023  Accepted January 7, 2024  
DOI: https://doi.org/10.5217/ir.2023.00077    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
The evolving understanding of histology as an endpoint in ulcerative colitis
Shintaro Akiyama, Yusuke Miyatani, David T. Rubin
Received September 13, 2023  Accepted January 24, 2023  
DOI: https://doi.org/10.5217/ir.2023.00120    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study
Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng
Received July 4, 2023  Accepted December 22, 2023  
DOI: https://doi.org/10.5217/ir.2023.00078    [Epub ahead of print]
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing
Rahiya Rehman, Muhammad Safwan Riaz, Dyadin Esharif, Phinnara Has, Michael Herzlinger, Jason Shapiro, Shova Subedi
Received August 1, 2023  Accepted December 6, 2023  
DOI: https://doi.org/10.5217/ir.2023.00091    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study
Katsuyoshi Matsuoka, Tomoyuki Inoue, Hiroaki Tsuchiya, Katsumasa Nagano, Toshiyuki Iwahori
Received June 21, 2023  Accepted November 6, 2023  
DOI: https://doi.org/10.5217/ir.2023.00071    [Epub ahead of print]
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Helminths in alternative therapeutics of inflammatory bowel disease
Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, Devi Lal
Received May 25, 2023  Accepted November 1, 2023  
DOI: https://doi.org/10.5217/ir.2023.00059    [Epub ahead of print]
Full text    PubReader    ePub    PDF    
Close layer
prev next
Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
Received June 3, 2023  Accepted September 14, 2023  
DOI: https://doi.org/10.5217/ir.2023.00062    [Epub ahead of print]
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
  • Journal Impact Factor 3.4
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD


ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next